IPHA
Innate Pharma
IPHA
IPHA
9 hedge funds and large institutions have $735K invested in Innate Pharma in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
$133K |
2 |
Citadel Advisors
Miami,
Florida
|
$41.7K |
3 |
![]()
RhumbLine Advisers
Boston,
Massachusetts
|
$643 |